Combined value of biopharma takeout deals worldwide 2017-2021, by therapy focus
From 2017 to 2021, there were nearly 120 billion U.S. dollars spent on takeout deals in the biopharmaceutical industry worldwide focused on oncology. In the same period, there were also around 69 billion U.S. dollars spent on deals targeting rare diseases. This statistic illustrates the combined value of biopharmaceutical industry deals worldwide in 2017-2021, by therapy focus.